Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group (vol 58, pg 1, 2017)

被引：0
|
作者：
Grzasko, R. [1 ]
Hajek, R. [1 ]
Hus, M. [1 ]
机构：
[1] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, Lublin, Poland
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 10期
关键词：
D O I：
10.1080/10428194.2017.1336361
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2518 / 2518
页数：1
相关论文
共 12 条
  • [1] Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group
    Grzasko, Norbert
    Hajek, Roman
    Hus, Marek
    Chocholska, Sylwia
    Morawska, Marta
    Giannopoulos, Krzysztof
    Czarnocki, Krzysztof
    Druzd-Sitek, Agnieszka
    Pienkowska-Grela, Barbara
    Rygier, Jolanta
    Usnarska-Zubkiewicz, Lidia
    Dytfeld, Dominik
    Kubicki, Tadeusz
    Jurczyszyn, Artur
    Korpysz, Maciej
    Dmoszynska, Anna
    LEUKEMIA & LYMPHOMA, 2017, 58 (09) : 2089 - 2100
  • [2] FGFR3 Mutations Are an Adverse Prognostic Factor in Patients with t(4;14)(p16; q32) Multiple Myeloma: An Mmrf Commpass Analysis
    Benard, Brooks
    Christofferson, Austin
    Legendre, Christophe
    Aldrich, Jessica
    Nasser, Sara
    Yesil, Jennifer
    Auclair, Daniel
    Liang, Winnie
    Lonial, Sagar
    Keats, Jonathan J.
    BLOOD, 2017, 130
  • [3] Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients
    Keats, JJ
    Maxwell, CA
    Taylor, BJ
    Hendzel, MJ
    Chesi, M
    Bergsagel, PL
    Larratt, LM
    Mant, MJ
    Reiman, T
    Belch, AR
    Pilarski, LM
    BLOOD, 2005, 105 (10) : 4060 - 4069
  • [4] Clinical implications of 13q14 and 17p13 deletion, t(4;14) and 1q21 amplification in patients with relapsed multiple myeloma treated by Thalidomide or Bortezomib (Velcade)
    Kuglik, P.
    Zaoralova, R.
    Filkova, H.
    Greslikova, H.
    Nemec, P.
    Oltova, A.
    Pour, L.
    Adam, Z.
    Krejci, M.
    Hajek, R.
    CHROMOSOME RESEARCH, 2007, 15 : 185 - 186
  • [5] Treatment Outcomes with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDex) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) and Del(17p13) and/or t(4;14)(p16;q32) Cytogenetic Abnormalities Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT)
    Richardson, Paul G.
    Jakubowiak, Andrzej
    Bahlis, Nizar J.
    Siegel, David S.
    Chen, Christine I.
    Chen, Min
    Zaki, Mohamed
    Larkins, Gail
    Anderson, Kenneth C.
    BLOOD, 2012, 120 (21)
  • [6] Chromosome 1p21 deletion defines a subgroup of multiple myeloma with poor clinical outcomes independent of del(13q), del(p53), t(4;14) or 1q21 amplification
    Chang, Hong
    Qi, Connie
    Jiang, Allan
    Xu, Wei
    Young, Trieu
    Mikhael, Joe
    Trudel, Suzanne
    Chen, Christine
    Reece, Donna
    BLOOD, 2007, 110 (11) : 730A - 730A
  • [7] Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma
    Thomas Smol
    Annika Dufour
    Sabine Tricot
    Mathieu Wemeau
    Laure Stalnikiewicz
    Franck Bernardi
    Christine Terré
    Benoît Ducourneau
    Hervé Bisiau
    Agnès Daudignon
    Molecular Cytogenetics, 10
  • [8] COMBINATION OF T(4;14), DEL(17P13), DEL(1P32) AND 1Q21 GAIN FISH PROBES IDENTIFIES CLONAL HETEROGENEITY AND ENHANCES DETECTION OF ADVERSE CYTOGENETIC PROFILES IN 233 NEWLY DIAGNOSED MULTIPLE MYELOMA
    Smol, T.
    Dufour, A.
    Tricot, S.
    Wemeau, M.
    Stalnikiewicz, L.
    Bernardi, F.
    Christine, T.
    Daudignon, A.
    HAEMATOLOGICA, 2016, 101 : 514 - 514
  • [9] Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma
    Smol, Thomas
    Dufour, Annika
    Tricot, Sabine
    Wemeau, Mathieu
    Stalnikiewicz, Laure
    Bernardi, Franck
    Terre, Christine
    Ducourneau, Benoit
    Bisiau, Herve
    Daudignon, Agnes
    MOLECULAR CYTOGENETICS, 2017, 10
  • [10] AN ASSAY FOR SIMULTANEOUS DIAGNOSIS OF T(4;14), T(11;14), T(14;16)/T(14;20), DEL1P, ADD1Q, DEL13Q, DEL17P, MS/MF EXPRESSION CLUSTERS, AND THE SKY-92 HIGH RISK SIGNATURE IN MULTIPLE MYELOMA PATIENTS
    Van Vliet, M.
    Kuiper, R.
    Broijl, A.
    de Knegt, Y.
    Hoos, W.
    de Best, L.
    van Duin, M.
    Van Beers, E.
    Sonneveld, P.
    HAEMATOLOGICA, 2013, 98 : 101 - 101
12